TrialJournal of neurology2018
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients.
Albulena Bajrami et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
TrialJournal of neurology2018
Albulena Bajrami et al.PubMed ↗Publisher ↗
No numbers read from the abstract.